Yvonne W. Elderkamp

883 total citations
5 papers, 725 citations indexed

About

Yvonne W. Elderkamp is a scholar working on Oncology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Yvonne W. Elderkamp has authored 5 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Immunology and Allergy. Recurrent topics in Yvonne W. Elderkamp's work include Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (2 papers) and Kruppel-like factors research (2 papers). Yvonne W. Elderkamp is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (2 papers) and Kruppel-like factors research (2 papers). Yvonne W. Elderkamp collaborates with scholars based in Netherlands. Yvonne W. Elderkamp's co-authors include Anton J.G. Horrevoets, Hans Pannekoek, Rob J. Dekker, Reinier A. Boon, Astrid Kragt, Oscar L. Volger, Joost C.M. Meijers, Jan Voorberg, Mariska G. Rondaij and Johannes V. van Thienen and has published in prestigious journals such as Blood, American Journal Of Pathology and Biochemical Pharmacology.

In The Last Decade

Yvonne W. Elderkamp

5 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yvonne W. Elderkamp Netherlands	5	497	117	97	95	84	5	725
Edward Rocnik Canada	11	330 0.7×	127 1.1×	59 0.6×	48 0.5×	64 0.8×	11	599
Sinny Delacroix Australia	13	512 1.0×	114 1.0×	186 1.9×	175 1.8×	68 0.8×	40	854
Miho Kobayashi Japan	12	404 0.8×	101 0.9×	53 0.5×	153 1.6×	99 1.2×	21	671
May Truongcao United States	11	441 0.9×	187 1.6×	111 1.1×	109 1.1×	68 0.8×	18	662
Barry Fine United States	11	389 0.8×	106 0.9×	94 1.0×	97 1.0×	42 0.5×	26	686
Heike Meýborg Germany	16	233 0.5×	128 1.1×	99 1.0×	64 0.7×	134 1.6×	31	574
Tomohisa Sakaue Japan	13	287 0.6×	78 0.7×	115 1.2×	91 1.0×	67 0.8×	41	570
Jimmy J.H. Kang Canada	10	312 0.6×	78 0.7×	124 1.3×	197 2.1×	50 0.6×	50	671
Gimbrone Ma United States	7	228 0.5×	78 0.7×	73 0.8×	46 0.5×	63 0.8×	10	538
Louise Tatton United Kingdom	8	354 0.7×	70 0.6×	45 0.5×	67 0.7×	197 2.3×	9	708

Countries citing papers authored by Yvonne W. Elderkamp

Since Specialization

Citations

This map shows the geographic impact of Yvonne W. Elderkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne W. Elderkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne W. Elderkamp more than expected).

Fields of papers citing papers by Yvonne W. Elderkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne W. Elderkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne W. Elderkamp. The network helps show where Yvonne W. Elderkamp may publish in the future.

Co-authorship network of co-authors of Yvonne W. Elderkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne W. Elderkamp. A scholar is included among the top collaborators of Yvonne W. Elderkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne W. Elderkamp. Yvonne W. Elderkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Dekker, Rob J., Reinier A. Boon, Mariska G. Rondaij, et al.. (2006). KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood. 107(11). 4354–4363. 285 indexed citations

2.

Dekker, Rob J., Johannes V. van Thienen, Jakub Rohlena, et al.. (2005). Endothelial KLF2 Links Local Arterial Shear Stress Levels to the Expression of Vascular Tone-Regulating Genes. American Journal Of Pathology. 167(2). 609–618. 289 indexed citations

3.

Hensbergen, Yvette van, Erna Peters, Sareena Rana, et al.. (2003). Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix. Thrombosis and Haemostasis. 90(11). 921–929. 8 indexed citations

4.

Hensbergen, Yvette van, Henk J. Broxterman, Yvonne W. Elderkamp, et al.. (2002). A doxorubicin–CNGRC-peptide conjugate with prodrug properties. Biochemical Pharmacology. 63(5). 897–908. 70 indexed citations

5.

Groot, Franciscus M. H. de, Henk J. Broxterman, G. I. Tesser, et al.. (2002). Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.. PubMed. 1(11). 901–11. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact